Overview

"Stop Early Age-related Macular Degeneration (AMD) From Vision Loss Eternally" Study

Status:
Unknown status
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
This study aims to validate the efficacy and safety of subthreshold laser photocoagulation on high-risk macular drusen in early age-related macular degeneration which has a high risk of conversion to exudative AMD.
Phase:
N/A
Details
Lead Sponsor:
Seoul National University Bundang Hospital
Treatments:
Bevacizumab